secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2025-11-17T23:59:59+00:00
Accession:  0001615219-25-000166
Event type: regulatory
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Salarius Pharmaceuticals corrects false delisting reports; remains listed on Nasdaq
--------------------------------------------------------------------------------

- Company statement that stock continues trading on Nasdaq Capital Market under ticker SLRX despite inaccurate Yahoo Finance and CapIQ delisting reports.
- Nasdaq compliance regained: Bid Price Rule (Sep 4, 2025) and Equity Standard (Oct 10, 2025) re-attained.
- Merger with Decoy Therapeutics completed Nov 13, 2025; no delisting notification received from Nasdaq.
- Company contacted financial data platforms to correct erroneous delisting information.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000161521925000166/0001615219-25-000166-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000161521925000166/flks-20251117.htm
  HTML page:      https://secwatch.observer/filing/0001615219-25-000166

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer